Rare diseases
Investigational molecules
Locations
Back to Germany143 clinical trials in Dortmund, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
GermanyStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
GermanyStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
GermanyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
GermanyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
GermanyEfficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma
GermanyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
GermanyA study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on various cancer types, including lymphomas, breast cancer, and hepatic tumors. Studies evaluate novel treatment combinations and personalized approaches.
Innovative protocols combining immunotherapy with conventional treatments to improve patient outcomes.
Extensive research into cardiovascular diseases, focusing on preventive treatments and management of acute conditions. Studies examine new approaches to reduce major cardiac events.
Novel therapies targeting lipid management and cardiovascular risk reduction.
Clinical investigations focusing on multiple sclerosis and other neurological conditions. Studies evaluate new treatment options and disease-modifying therapies.
Research aims to improve patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
